RA CAPITAL MANAGEMENT, L.P.

Holdings History for Janux Therapeutics, Inc. - Common Stock (JANX)

Symbol: JANX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 11,971,377 shares
Security Ownership %: 20%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in Janux Therapeutics, Inc. Common Stock (JANX)

10 Mar 2025 - RA Capital Management, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 11,971,377 shares of Janux Therapeutics, Inc. Common Stock (JANX). This represents 20% ownership of the company. This is the first filing by RA CAPITAL MANAGEMENT, L.P. disclosing ownership of Janux Therapeutics, Inc. Common Stock (JANX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
RA Capital Management, L.P.	20%		$383,922,060	11,971,377			$32.07	13D/A	06 Mar 2025	10 Mar 2025, 16:33

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	1.6%	0%	$154,417,763	11,189,693	0		$13.80	Q4 2025
30 Sep 2025	3.4%	0%	$273,476,097	11,189,693	0		$24.44	Q3 2025
30 Jun 2025	4.4%	0%	$258,481,908	11,189,693	0		$23.10	Q2 2025
31 Mar 2025	5%	+0.37%	$302,121,711	11,189,693	+824,041		$27.00	Q1 2025
31 Dec 2024	7.4%	+0.86%	$554,977,008	10,365,652	+1,200,000	+13%	$53.54	Q4 2024
30 Sep 2024	4.8%	0%	$416,395,570	9,165,652	0		$45.43	Q3 2024
30 Jun 2024	5.1%	0%	$383,949,162	9,165,652	0		$41.89	Q2 2024
31 Mar 2024	4.4%	0%	$345,086,798	9,165,652	0		$37.65	Q1 2024
31 Dec 2023	1.5%	0%	$98,347,446	9,165,652	0		$10.73	Q4 2023
30 Sep 2023	1.8%	+0.1%	$92,389,772	9,165,652	+495,008	+5.7%	$10.08	Q3 2023
30 Jun 2023	1.9%	0%	$102,920,544	8,670,644	0		$11.87	Q2 2023
31 Mar 2023	2.4%	0%	$104,914,792	8,670,644	0		$12.10	Q1 2023
31 Dec 2022	2.3%	0%	$114,192,381	8,670,644	0		$13.17	Q4 2022
30 Sep 2022	2.5%	0%	$117,401,000	8,670,644	0		$13.54	Q3 2022
30 Jun 2022	2.8%	0%	$105,869,000	8,670,644	0		$12.21	Q2 2022
31 Mar 2022	2.7%	0%	$124,337,000	8,670,644	0		$14.34	Q1 2022
31 Dec 2021	3%	0%	$171,072,000	8,670,644	0		$19.73	Q4 2021
30 Sep 2021	2.6%	0%	$187,546,000	8,670,644	0		$21.63	Q3 2021
30 Jun 2021	3.5%	+3.5%	$216,333,000	8,670,644	+8,670,644	NEW	$24.95	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.